Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 925 KB, PDF document
The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.
Original language | English |
---|---|
Journal | Cephalalgia |
Volume | 43 |
Issue number | 8 |
Number of pages | 25 |
ISSN | 0333-1024 |
DOIs | |
Publication status | Published - 2023 |
Bibliographical note
Publisher Copyright:
© International Headache Society 2023.
- drug, Guidelines, headache, Idiopathic intracranial hypertension, lumbar puncture, papilloedema, Pseudotumor cerebri, raised intracranial pressure, Randomised control trial, vision
Research areas
ID: 386601203